Back
HCV Treatment 
Alternative & Complementary Therapy
Alternative & Complementary Therapy
Milk Thistle Drug May Help Control HCV Replication after Liver Transplant
- Details
- Category: HCV Treatment
- Published on Thursday, 28 February 2013 00:00
- Written by Liz Highleyman
Silibinin, a medication derived from the milk thistle plant, lowered hepatitis C virus (HCV) levels in patients awaiting liver transplantation in a pilot study, which may help reduce the risk of HCV recurrence in the new liver, Spanish researchers reported in the March 2013 Journal of Hepatology.
More Articles...
- Milk Thistle Fails to Reduce Liver Inflammation in Non-responder Hepatitis C Patients
- Green Tea Component May Help Prevent HCV Re-infection after Liver Transplant
- Occasional Marijuana Smoking Does Not Cause Long-Term Lung Damage
- AASLD: Milk Thistle Extract Did Not Improve Liver Inflammation or Quality of Life for Hepatitis C Patients
Web Design and Development by